By InvitationNot Applicable

The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study

800 participantsStarted 2007-06-14

Plain-language summary

To prospectively study novel blood and lung biomarkers of disease activity in patients with IPF and other interstitial lung disease with the aims of prognostic modelling and disease clustering

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with interstitial lung disease attending the Edinburgh Lung Fibrosis service Exclusion Criteria: * candidates not a suitable for enrolment or unlikely to comply with the requirements of this study, in the opinion of the investigator, will be excluded.

What they're measuring

Time to death (all cause)

Timeframe: 15 years

Trial details

NCT IDNCT04016181

SponsorUniversity of Edinburgh

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Idiopathic Pulmonary Fibrosis trials